ADHD Dosing Has Two Failure Modes, and Trials Are Designed to Miss Both
ADHD Dosing Has Two Failure Modes, and Trials Are Designed to Miss Both
www.clinicaltrialvanguard.com
ADHD Dosing Has Two Failure Modes, and Trials Are Designed to Miss Both
A Lancet Psychiatry network meta-analysis of ADHD pharmacotherapy exposes therapeutic inertia and uncritical dose escalation as twin hazards—with direct…
